Bright Minds Biosciences Statistics
Total Valuation
DRUG has a market cap or net worth of $198.09 million. The enterprise value is $157.63 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, before market open.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
DRUG has 7.08 million shares outstanding. The number of shares has increased by 39.99% in one year.
Current Share Class | 7.08M |
Shares Outstanding | 7.08M |
Shares Change (YoY) | +39.99% |
Shares Change (QoQ) | +5.97% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 2.98M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 5.11 |
P/TBV Ratio | 5.11 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 88.27, with a Debt / Equity ratio of 0.00.
Current Ratio | 88.27 |
Quick Ratio | 87.64 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -183.80 |
Financial Efficiency
Return on equity (ROE) is -11.21% and return on invested capital (ROIC) is -10.80%.
Return on Equity (ROE) | -11.21% |
Return on Assets (ROA) | -10.57% |
Return on Invested Capital (ROIC) | -10.80% |
Return on Capital Employed (ROCE) | -9.54% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2,250.43% in the last 52 weeks. The beta is 1.19, so DRUG's price volatility has been higher than the market average.
Beta (5Y) | 1.19 |
52-Week Price Change | +2,250.43% |
50-Day Moving Average | 31.37 |
200-Day Moving Average | 29.54 |
Relative Strength Index (RSI) | 39.65 |
Average Volume (20 Days) | 29,490 |
Short Selling Information
The latest short interest is 80,327, so 1.13% of the outstanding shares have been sold short.
Short Interest | 80,327 |
Short Previous Month | 86,838 |
Short % of Shares Out | 1.13% |
Short % of Float | 2.69% |
Short Ratio (days to cover) | 2.85 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -3.71M |
Pretax Income | -3.82M |
Net Income | -2.40M |
EBITDA | n/a |
EBIT | -3.71M |
Earnings Per Share (EPS) | -$0.44 |
Full Income Statement Balance Sheet
The company has $38.74 million in cash and $115,905 in debt, giving a net cash position of $38.62 million or $5.45 per share.
Cash & Cash Equivalents | 38.74M |
Total Debt | 115,905 |
Net Cash | 38.62M |
Net Cash Per Share | $5.45 |
Equity (Book Value) | 38.78M |
Book Value Per Share | 5.48 |
Working Capital | 38.74M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -2.88M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
DRUG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -39.99% |
Shareholder Yield | -39.99% |
Earnings Yield | -1.21% |
FCF Yield | n/a |
Analyst Forecast
The average price target for DRUG is $83.25, which is 199.95% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $83.25 |
Price Target Difference | 199.95% |
Analyst Consensus | Strong Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 14, 2023. It was a reverse split with a ratio of 0.2:1.
Last Split Date | Jul 14, 2023 |
Split Type | Reverse |
Split Ratio | 0.2:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |